These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 31995996)
1. Intrapleural alteplase therapy: what are the knowns and unknowns? Staša J; Gregorová J; Pauk N Cas Lek Cesk; 2019; 158(7-8):295-299. PubMed ID: 31995996 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema. Thommi G; Nair CK; Aronow WS; Shehan C; Meyers P; McLeay M Am J Ther; 2007; 14(4):341-5. PubMed ID: 17667208 [TBL] [Abstract][Full Text] [Related]
3. Intrapleural alteplase in a patient with complicated pleural effusion. Walker CA; Shirk MB; Tschampel MM; Visconti JA Ann Pharmacother; 2003 Mar; 37(3):376-9. PubMed ID: 12639166 [TBL] [Abstract][Full Text] [Related]
4. Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns. Idell S; Rahman NM Ann Am Thorac Soc; 2018 May; 15(5):515-517. PubMed ID: 29361235 [No Abstract] [Full Text] [Related]
5. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Wells RG; Havens PL Radiology; 2003 Aug; 228(2):370-8. PubMed ID: 12893898 [TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients. Israel EN; Blackmer AB Pharmacotherapy; 2014 May; 34(5):521-32. PubMed ID: 24390857 [TBL] [Abstract][Full Text] [Related]
7. Intrapleural Fibrinolysis with Urokinase Versus Alteplase in Complicated Parapneumonic Pleural Effusions and Empyemas: A Prospective Randomized Study. Alemán C; Porcel JM; Alegre J; Ruiz E; Bielsa S; Andreu J; Deu M; Suñé P; Martínez-Sogués M; López I; Pallisa E; Schoenenberger JA; Bruno Montoro J; de Sevilla TF Lung; 2015 Dec; 193(6):993-1000. PubMed ID: 26423784 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials. Nie W; Liu Y; Ye J; Shi L; Shao F; Ying K; Zhang R Clin Respir J; 2014 Jul; 8(3):281-91. PubMed ID: 24428897 [TBL] [Abstract][Full Text] [Related]
9. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159 [TBL] [Abstract][Full Text] [Related]
10. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax]. Kemper P; Köhler D Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276 [TBL] [Abstract][Full Text] [Related]
11. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cameron R; Davies HR Cochrane Database Syst Rev; 2008 Apr; (2):CD002312. PubMed ID: 18425881 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial. Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642 [TBL] [Abstract][Full Text] [Related]
13. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Zhu Z; Hawthorne ML; Guo Y; Drake W; Bilaceroglu S; Misra HL; Light RW Chest; 2006 Jun; 129(6):1577-83. PubMed ID: 16778278 [TBL] [Abstract][Full Text] [Related]
14. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema. Singh G; Pitoyo CW; Nasir AU; Rumende CM; Amin Z Acta Med Indones; 2012 Jul; 44(3):258-64. PubMed ID: 22983084 [TBL] [Abstract][Full Text] [Related]
15. Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation. Hanson SJ; Havens PL; Simpson PM; Nugent ML; Wells RG Pediatr Pulmonol; 2015 Dec; 50(12):1328-35. PubMed ID: 25847131 [TBL] [Abstract][Full Text] [Related]
16. Alteplase and DNase for the treatment of pleural empyema in rats. Gehlen M; Fraga JC; Amantea SL; Silveira NP; Kulczynski J; Roesch E; Portal KG; Sanches PR Pulm Pharmacol Ther; 2019 Apr; 55():1-4. PubMed ID: 30648619 [TBL] [Abstract][Full Text] [Related]
17. The Use of Intrapleural Thrombolytic or Fibrinolytic Therapy, or Both, via Indwelling Tunneled Pleural Catheters With or Without Concurrent Anticoagulation Use. Gilbert CR; Wilshire CL; Chang SC; Gorden JA Chest; 2021 Aug; 160(2):776-783. PubMed ID: 33745991 [TBL] [Abstract][Full Text] [Related]
18. The first use of combination of Intrapleural Fibrinolytics (Alteplase & DNAse) for pleural infection in Malaysia. Muhammad Redzwan SRA Med J Malaysia; 2019 Apr; 74(2):176-178. PubMed ID: 31079131 [TBL] [Abstract][Full Text] [Related]
19. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema. Khemasuwan D; Sorensen J; Griffin DC Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674 [TBL] [Abstract][Full Text] [Related]
20. Intra-pleural fibrinolytic therapy vs. conservative management in the treatment of parapneumonic effusions and empyema. Cameron R Cochrane Database Syst Rev; 2000; (3):CD002312. PubMed ID: 10908554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]